Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by MustangSalleyon May 20, 2021 9:36pm
140 Views
Post# 33245944

RE:RE:RE:RE:RE:RE:RE:RE:RE:anyone know

RE:RE:RE:RE:RE:RE:RE:RE:RE:anyone knowCowjazz, I am talking about preclinical in the lab on animals . What they have only had it for two years now and they can't have their scientists graft the pouch in a mouse with immune cloaked cells ? What is he waiting for Cowjazz?  This preclinical prof of concept is required to get Fda approval for TD1 trials but more importantly needed to show pharma that Sva has solved the issue of immunosuppresion.

My statements are not fallacy call management and ask them Cowjazz.  Go ahead and tell me what management says .  So where is all the flood of buying from the sophisticated European investors ? Toleikis must of gave them a different presentation than what he gave his unsophisticated retail investors . 
<< Previous
Bullboard Posts
Next >>